BioSpace News Archive

As trial sponsor, Celltex will provide adult autologous adipose tissue-derived mesenchymal stem cells (AdMSCs) cultured and expanded by Celltex’s proprietary stem cell process, which yields adult autologous AdMSCs in quantities never possible for use in therapies for vascular, autoimmune, and degenerative diseases, as well as injuries.

Sharing Images with Patients and Providers through myBaystateHealth

A breakthrough analytics application featuring next-generation benchmarking and prioritization capabilities powered by Artificial Intelligence (AI) to supercharge healthcare improvement initiatives.

Study Steering Committee approves opening cohorts for dosing to deep tumors and more frequent treatment into superficial tumors

Procedures May Now Be Performed on Patients as Young as 18.

For the first time, a major scientific study has confirmed what cannabis advocates have known for decades: that cannabis can be a safe and effective palliative treatment in patients suffering from the debilitating effects of cancer.

FaceTite and BodyTite are non-excisional devices that utilize radio-frequency assisted lipolysis (RFAL) to address the shortcomings often associated with traditional liposuction or surgical face and body lifts, including sagging or wrinkly skin and scarring.

TP Therapeutics, Inc., a privately held, clinical-stage biopharmaceutical company focusing on addressing oncology drug resistance, announced the appointment of Lewis “Lew” Shuster to the Company’s Board of Directors.

AIVITA Biomedical, a global bio-tech wellness company specializing in novel stem cell applications, announced today its participation in three upcoming aesthetic and dermatology conferences in support of its recently launched ROOT OF SKIN™ and soon-to-launch ROOT OF SKIN™ MD skincare lines.

Amarantus BioScience Holdings, Inc. (OTCPK: AMBS) (the “Company” or AMBS), a US-based biotechnology holding company with wholly-owned subsidiaries...